Thryv Quarterly Balance Sheets Chart
Quarterly
|
Annual
Thryv Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||
current assets | ||||||||||||||||||||||||||||||
cash and cash equivalents | 10,838,000 | 10,993,000 | 16,311,000 | 12,453,000 | 15,519,000 | 14,394,000 | 14,676,000 | 15,245,000 | 15,395,000 | 16,031,000 | 14,312,000 | 13,746,000 | 21,446,000 | 11,262,000 | 10,374,000 | 15,785,000 | 29,841,000 | 2,406,000 | 1,771,000 | 192,000,000 | 191,000,000 | 171,000,000 | 171,000,000 | 145,000,000 | 146,000,000 | 179,000,000 | 156,000,000 | 234,000,000 | 244,000,000 | 0.1 |
accounts receivable | 133,658,000 | 139,894,000 | 161,620,000 | 176,364,000 | 193,725,000 | 204,119,000 | 198,828,000 | 243,893,000 | 271,905,000 | 284,698,000 | 290,103,000 | 296,619,000 | 305,729,000 | 279,053,000 | 313,285,000 | 312,457,000 | 354,737,000 | 296,570,000 | 326,240,000 | 124,000,000 | 131,000,000 | 142,000,000 | 151,000,000 | 151,000,000 | 168,000,000 | 175,000,000 | 218,000,000 | 176,000,000 | 209,000,000 | |
contract assets, net of allowance of 47 in 2025 and 29 in 2024 | 2,665,000 | |||||||||||||||||||||||||||||
taxes receivable | 7,136,000 | 7,493,000 | 6,218,000 | 2,706,000 | 1,516,000 | 2,855,000 | 19,087,000 | 3,640,000 | 7,918,000 | 11,553,000 | 12,860,000 | 14,821,000 | 15,248,000 | 14,711,000 | 1,890,000 | 1,890,000 | 9,154,000 | 9,229,000 | 27,818,000 | |||||||||||
prepaid expenses | 21,716,000 | 30,806,000 | 13,923,000 | 18,383,000 | 23,124,000 | 31,606,000 | 22,801,000 | 29,318,000 | 39,580,000 | 25,092,000 | 28,253,000 | 32,463,000 | 43,112,000 | 22,418,000 | ||||||||||||||||
deferred costs | 10,772,000 | 9,486,000 | 8,402,000 | 10,184,000 | 12,796,000 | 15,106,000 | 15,085,000 | 11,821,000 | ||||||||||||||||||||||
other current assets | 2,282,000 | 2,035,000 | 2,119,000 | 1,780,000 | 5,822,000 | 2,359,000 | 2,624,000 | 15,557,000 | 24,463,000 | 11,864,000 | 12,626,000 | 13,470,000 | 14,572,000 | 13,596,000 | 3,000,000 | 2,000,000 | ||||||||||||||
total current assets | 189,067,000 | 202,687,000 | 210,720,000 | 230,938,000 | 260,620,000 | 275,017,000 | 274,572,000 | 309,399,000 | 388,631,000 | 378,316,000 | 387,093,000 | 399,906,000 | 428,915,000 | 370,645,000 | 391,251,000 | 400,107,000 | 463,640,000 | 369,698,000 | 424,248,000 | 507,000,000 | 476,000,000 | 475,000,000 | 497,000,000 | 497,000,000 | 535,000,000 | 581,000,000 | 609,000,000 | 793,000,000 | 893,000,000 | |
fixed assets and capitalized software | 41,863,000 | 41,998,000 | 44,478,000 | 37,142,000 | 37,805,000 | 37,836,000 | 37,951,000 | 38,569,000 | 38,115,000 | 42,334,000 | 42,144,000 | 45,078,000 | 49,965,000 | 50,938,000 | 70,269,000 | 76,315,000 | 123,281,000 | 89,044,000 | 86,429,000 | 38,000,000 | 45,000,000 | 54,000,000 | 64,000,000 | 76,000,000 | 84,000,000 | 92,000,000 | 106,000,000 | 120,000,000 | 128,000,000 | |
goodwill | 253,809,000 | 253,809,000 | 253,318,000 | 218,884,000 | 300,995,000 | 299,626,000 | 567,773,000 | 569,780,000 | 564,934,000 | 566,004,000 | 664,619,000 | 668,821,000 | 673,713,000 | 671,886,000 | 676,440,000 | 678,793,000 | 679,559,000 | 609,457,000 | 609,457,000 | 315,000,000 | 315,000,000 | 315,000,000 | 315,000,000 | 315,000,000 | 315,000,000 | 315,000,000 | 315,000,000 | 396,000,000 | 396,000,000 | |
intangible assets | 29,804,000 | 31,956,000 | 34,259,000 | 3,453,000 | 6,640,000 | 11,626,000 | 24,268,000 | 31,321,000 | 33,019,000 | 34,715,000 | 45,330,000 | 61,387,000 | 77,457,000 | 82,577,000 | 101,189,000 | 123,907,000 | 145,647,000 | 31,777,000 | 60,561,000 | 515,000,000 | 608,000,000 | 701,000,000 | 794,000,000 | 941,000,000 | 1,088,000,000 | 1,234,000,000 | 1,381,000,000 | 1,991,000,000 | 2,217,000,000 | |
deferred tax assets | 141,502,000 | 146,530,000 | 143,495,000 | 139,769,000 | 152,171,000 | 131,357,000 | 114,406,000 | 122,548,000 | 115,796,000 | 113,859,000 | 126,721,000 | 118,639,000 | 108,912,000 | 90,565,000 | 114,062,000 | 106,069,000 | 97,941,000 | 93,099,000 | 47,000,000 | 9,000,000 | 9,000,000 | 12,000,000 | 9,000,000 | 34,000,000 | ||||||
other assets | 31,659,000 | 26,754,000 | 25,895,000 | 24,567,000 | 27,252,000 | 31,373,000 | 21,412,000 | 29,610,000 | 31,772,000 | 42,649,000 | 23,974,000 | 26,503,000 | 30,753,000 | 33,891,000 | 24,278,000 | 26,944,000 | 34,410,000 | 21,902,000 | 10,576,000 | |||||||||||
total assets | 687,704,000 | 703,734,000 | 712,165,000 | 654,753,000 | 785,483,000 | 786,835,000 | 1,040,382,000 | 1,101,227,000 | 1,172,267,000 | 1,177,877,000 | 1,289,881,000 | 1,320,334,000 | 1,369,715,000 | 1,300,502,000 | 1,377,489,000 | 1,412,135,000 | 1,544,478,000 | 1,214,977,000 | 1,214,046,000 | 1,419,000,000 | 1,494,000,000 | 1,600,000,000 | 1,722,000,000 | 1,898,000,000 | 2,084,000,000 | 2,275,000,000 | 2,464,000,000 | 3,358,000,000 | 3,701,000,000 | 0.1 |
liabilities and stockholders' equity | ||||||||||||||||||||||||||||||
current liabilities | ||||||||||||||||||||||||||||||
accounts payable | 3,926,000 | 5,894,000 | 13,011,000 | 6,946,000 | 8,661,000 | 19,743,000 | 8,138,000 | 7,341,000 | 8,980,000 | 18,972,000 | 18,203,000 | 8,254,000 | 16,433,000 | 8,610,000 | 16,929,000 | 30,024,000 | 19,981,000 | 8,927,000 | 16,215,000 | |||||||||||
accrued liabilities | 85,612,000 | 80,828,000 | 95,462,000 | 98,439,000 | 110,193,000 | 89,142,000 | 97,720,000 | 106,606,000 | 127,229,000 | 126,810,000 | 133,063,000 | 143,559,000 | 146,350,000 | 131,813,000 | 153,234,000 | 168,602,000 | 157,537,000 | 139,613,000 | 165,903,000 | |||||||||||
current portion of unrecognized tax benefits | 27,224,000 | 26,703,000 | 26,196,000 | 25,623,000 | 25,060,000 | 24,515,000 | 23,415,000 | 22,969,000 | 32,675,000 | 31,919,000 | 31,243,000 | 30,658,000 | 30,171,000 | 29,771,000 | 31,018,000 | 30,615,000 | 30,417,000 | 30,022,000 | 32,259,000 | |||||||||||
contract liabilities | 27,060,000 | 42,873,000 | 40,315,000 | 32,534,000 | 25,668,000 | 45,846,000 | 27,119,000 | 20,136,000 | 47,782,000 | 41,854,000 | 31,733,000 | 24,041,000 | 61,471,000 | 51,726,000 | 35,109,000 | 32,233,000 | 47,909,000 | 18,942,000 | 18,769,000 | |||||||||||
current portion of term loan | 5,250,000 | 15,750,000 | 7,875,000 | 35,783,000 | 35,783,000 | |||||||||||||||||||||||||
current portion of term loan, related party | 3,500,000 | 10,500,000 | 5,250,000 | 16,717,000 | 16,717,000 | |||||||||||||||||||||||||
other current liabilities | 5,326,000 | 6,847,000 | 8,151,000 | 5,906,000 | 6,022,000 | 7,953,000 | 9,522,000 | 10,887,000 | 10,164,000 | 10,937,000 | 11,644,000 | 17,069,000 | 18,114,000 | 15,214,000 | 14,238,000 | 12,898,000 | 20,324,000 | 9,896,000 | ||||||||||||
total current liabilities | 157,898,000 | 189,395,000 | 196,260,000 | 221,948,000 | 228,104,000 | 239,699,000 | 235,914,000 | 237,939,000 | 296,830,000 | 300,492,000 | 295,886,000 | 293,581,000 | 342,539,000 | 307,134,000 | 320,528,000 | 344,372,000 | 346,168,000 | 207,400,000 | 249,690,000 | 2,506,000,000 | 342,000,000 | 360,000,000 | 404,000,000 | 364,000,000 | 396,000,000 | 419,000,000 | 466,000,000 | 461,000,000 | 532,000,000 | |
term loan | 134,862,000 | 139,565,000 | 146,885,000 | 157,794,000 | 183,772,000 | 239,331,000 | 253,874,000 | 295,179,000 | 311,483,000 | 345,256,000 | 349,044,000 | 382,254,000 | 375,422,000 | |||||||||||||||||
term loan, net, related party | 92,075,000 | 95,382,000 | 100,436,000 | 75,610,000 | 87,820,000 | |||||||||||||||||||||||||
abl facility | 39,916,000 | 37,790,000 | 23,891,000 | 21,900,000 | 18,000,000 | 55,737,000 | 57,393,000 | 68,278,000 | 72,231,000 | 54,554,000 | 58,856,000 | 56,609,000 | 62,975,000 | 39,929,000 | 56,181,000 | 58,022,000 | 43,682,000 | 79,238,000 | 81,641,000 | |||||||||||
pension obligations | 39,258,000 | 38,699,000 | 38,014,000 | 73,723,000 | 72,279,000 | 70,828,000 | 76,076,000 | 74,321,000 | 72,584,000 | 72,590,000 | 111,942,000 | 115,655,000 | 132,456,000 | 140,167,000 | 168,793,000 | 174,217,000 | 184,642,000 | 190,827,000 | 198,290,000 | |||||||||||
other liabilities | 8,811,000 | 9,672,000 | 9,759,000 | 9,246,000 | 12,448,000 | 14,174,000 | 20,029,000 | 21,184,000 | 24,086,000 | 22,205,000 | 25,568,000 | 28,049,000 | 31,606,000 | 35,212,000 | 41,318,000 | 44,756,000 | 48,947,000 | 36,266,000 | 623,000 | 4,000,000 | 3,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | ||
total long-term liabilities | 314,922,000 | 321,108,000 | 318,985,000 | 338,273,000 | 374,319,000 | 380,070,000 | 407,372,000 | 458,962,000 | 480,384,000 | 495,118,000 | 572,069,000 | 615,139,000 | 670,735,000 | 678,653,000 | 752,516,000 | 798,060,000 | 969,114,000 | 810,802,000 | 927,501,000 | |||||||||||
commitments and contingencies | ||||||||||||||||||||||||||||||
stockholders' equity | ||||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 71,703,175 shares issued and 43,926,392 shares outstanding at june 30, 2025; and 70,556,740 shares issued and 43,033,960 shares outstanding at december 31, 2024 | 717,000 | |||||||||||||||||||||||||||||
additional paid-in capital | 1,290,326,000 | 1,282,424,000 | 1,272,476,000 | 1,177,078,000 | 1,170,798,000 | 1,159,754,000 | 1,143,493,000 | 1,121,804,000 | 1,112,420,000 | 1,105,701,000 | 1,099,313,000 | 1,094,362,000 | 1,087,054,000 | 1,084,288,000 | 1,079,340,000 | 1,076,124,000 | 1,058,504,000 | 1,059,624,000 | 1,008,243,000 | 1,556,000,000 | 1,556,000,000 | 1,555,000,000 | 1,554,000,000 | 1,553,000,000 | 1,553,000,000 | 1,552,000,000 | 1,551,000,000 | 1,551,000,000 | 1,551,000,000 | |
treasury stock | -492,854,000 | -492,744,000 | -488,903,000 | -488,824,000 | -488,757,000 | -488,087,000 | -485,768,000 | -485,730,000 | -469,941,000 | -468,879,000 | -468,879,000 | -468,879,000 | -468,879,000 | -468,879,000 | -468,613,000 | -468,613,000 | -468,613,000 | -468,613,000 | -467,331,000 | |||||||||||
accumulated other comprehensive loss | -15,200,000 | -15,128,000 | -14,941,000 | -14,059,000 | -15,389,000 | -15,456,000 | -20,593,000 | -8,047,000 | ||||||||||||||||||||||
accumulated deficit | -568,105,000 | -582,036,000 | -572,418,000 | -580,301,000 | -484,230,000 | -489,778,000 | -240,661,000 | -213,615,000 | -229,593,000 | -238,907,000 | -188,462,000 | -201,742,000 | -259,744,000 | -293,255,000 | -298,343,000 | -333,967,000 | -358,326,000 | -394,832,000 | -504,632,000 | |||||||||||
total stockholders' equity | 214,884,000 | 193,231,000 | 196,920,000 | 94,532,000 | 183,060,000 | 167,066,000 | 397,096,000 | 404,326,000 | 395,053,000 | 382,267,000 | 421,926,000 | 411,614,000 | 356,441,000 | 314,715,000 | 304,445,000 | 269,703,000 | 229,196,000 | 196,775,000 | 36,855,000 | |||||||||||
total liabilities and stockholders' equity | 687,704,000 | 703,734,000 | 712,165,000 | 654,753,000 | 785,483,000 | 786,835,000 | 1,040,382,000 | 1,101,227,000 | 1,172,267,000 | 1,177,877,000 | 1,289,881,000 | 1,320,334,000 | 1,369,715,000 | 1,300,502,000 | 1,377,489,000 | 1,412,135,000 | 1,544,478,000 | 1,214,977,000 | 1,214,046,000 | |||||||||||
contract assets, net of allowance of 33 in 2025 and 29 in 2024 | 1,980,000 | |||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 71,496,077 shares issued and 43,728,331 shares outstanding at march 31, 2025; and 70,556,740 shares issued and 43,033,960 shares outstanding at december 31, 2024 | 715,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 29 in 2024 and 35 in 2023 | 2,127,000 | |||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 70,556,740, shares issued and 43,033,960 shares outstanding at december 31, 2024; and 62,660,783 shares issued and 35,302,746 shares outstanding at december 31, 2023 | 706,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 33 in 2024 and 35 in 2023 | 9,068,000 | |||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 63,840,032 shares issued and 36,322,417 shares outstanding at september 30, 2024; and 62,660,783 shares issued and 35,302,746 shares outstanding at december 31, 2023 | 638,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 37 in 2024 and 35 in 2023 | 8,118,000 | |||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 63,808,097 shares issued and 36,294,269 shares outstanding at june 30, 2024; and 62,660,783 shares issued and 35,302,746 shares outstanding at december 31, 2023 | 638,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 39 in 2024 and 35 in 2023 | 4,578,000 | |||||||||||||||||||||||||||||
current portion of long-term debt | 52,500,000 | 70,000,000 | 70,000,000 | 70,000,000 | 70,000,000 | 70,000,000 | 70,000,000 | 70,000,000 | 70,000,000 | 70,000,000 | ||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 63,306,246 shares issued and 35,826,908 shares outstanding at march 31, 2024; and 62,660,783 shares issued and 35,302,746 shares outstanding at december 31, 2023 | 633,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 23 in 2023 and 33 in 2022 | 1,471,000 | |||||||||||||||||||||||||||||
indemnification asset | 27,250,000 | 26,495,000 | 25,818,000 | 25,233,000 | 24,746,000 | 24,346,000 | 25,594,000 | 25,190,000 | 24,346,000 | 24,346,000 | 25,911,000 | |||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 62,521,026 shares issued and 35,164,339 shares outstanding at september 30, 2023; and 61,279,379 shares issued and 34,593,837 shares outstanding at december 31, 2022 | 625,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 28 in 2023 and 33 in 2022 | 1,746,000 | |||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 61,832,315 shares issued and 34,477,286 shares outstanding at june 30, 2023; and 61,279,379 shares issued and 34,593,837 shares outstanding at december 31, 2022 | 618,000 | |||||||||||||||||||||||||||||
accumulated other comprehensive income | -18,751,000 | -18,449,000 | -16,261,000 | -20,658,000 | -12,738,000 | -2,599,000 | -8,545,000 | -4,445,000 | -2,967,000 | |||||||||||||||||||||
contract assets, net of allowance of 30 in 2023 and 33 in 2022 | 2,120,000 | |||||||||||||||||||||||||||||
deferred tax liabilities | 513,000 | 832,000 | 2,224,000 | 7,374,000 | 10,798,000 | 1,179,000 | 30,706,000 | 508,000 | 12,391,000 | 65,000,000 | 28,000,000 | 29,000,000 | 30,000,000 | 29,000,000 | 31,000,000 | 35,000,000 | 28,000,000 | 161,000,000 | 178,000,000 | |||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 61,557,811 shares issued and 34,817,979 shares outstanding at march 31, 2023; and 61,279,379 shares issued and 34,593,837 shares outstanding at december 31, 2022 | 616,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 33 in 2022 and 88 in 2021 | 2,583,000 | |||||||||||||||||||||||||||||
term loan, related party | 25,827,000 | 30,348,000 | 60,902,000 | |||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 61,279,379, shares issued and 34,593,837 shares outstanding at december 31, 2022; and 60,830,853 shares issued and 34,145,311 shares outstanding at december 31, 2021 | 613,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 42 in 2022 and 88 in 2021 | 3,121,000 | |||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 61,160,731 shares issued and 34,475,189 shares outstanding at september 30, 2022; and 60,830,853 shares issued and 34,145,311 shares outstanding at december 31, 2021 | 612,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 50 in 2022 and 88 in 2021 | 3,554,000 | |||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 61,121,058 shares issued and 34,435,516 shares outstanding at june 30, 2022; and 60,830,853 shares issued and 34,145,311 shares outstanding at december 31, 2021 | 611,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 59 in 2022 and 88 in 2021 | 4,062,000 | |||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 60,913,663 shares issued and 34,228,121 shares outstanding at march 31, 2022; and 60,830,853 shares issued and 34,145,311 shares outstanding at december 31, 2021 | 609,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 88 in 2021 and 338 in 2020 | 5,259,000 | |||||||||||||||||||||||||||||
new term loan | 309,672,000 | 333,938,000 | 365,189,000 | 372,454,000 | ||||||||||||||||||||||||||
new term loan, related party | 142,875,000 | 152,286,000 | 154,697,000 | 234,098,000 | ||||||||||||||||||||||||||
senior term loan | ||||||||||||||||||||||||||||||
senior term loan, related party | 113,482,000 | 155,600,000 | ||||||||||||||||||||||||||||
leaseback obligations | 54,585,000 | 54,798,000 | ||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 60,830,853, shares issued and 34,145,311 shares outstanding at december 31, 2021; and 59,590,422 shares issued and 32,912,012 shares outstanding at december 31, 2020 | 608,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 114 in 2021 and 338 in 2020 | 7,024,000 | |||||||||||||||||||||||||||||
prepaid expenses and other current assets | 33,084,000 | 36,370,000 | 36,277,000 | 26,172,000 | ||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 60,643,781, shares issued and 33,965,371 shares outstanding at september 30, 2021; and 59,590,422 shares issued and 32,912,012 shares outstanding at december 31, 2020 | 606,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 157 and 338 | 8,415,000 | |||||||||||||||||||||||||||||
new term loan, current | 70,000,000 | 70,000,000 | ||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 60,391,597, shares issued and 33,713,187 shares outstanding at june 30, 2021; and 59,590,422 shares issued and 32,912,012 shares outstanding at december 31, 2020 | 604,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 244 and 338 | 9,285,000 | |||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 59,806,077, shares issued and 33,127,667 shares outstanding at march 31, 2021; and 59,590,422 shares issued and 32,912,012 shares outstanding at december 31, 2020 | 598,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 338 and 0 | 10,975,000 | |||||||||||||||||||||||||||||
senior term loan, net of debt issuance costs of 445 and 593 | 335,683,000 | |||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 59,590,422, shares issued and 32,912,012 shares outstanding as of december 31, 2020; and 57,443,282 shares issued and 33,490,526 shares outstanding as of december 31, 2019 | 596,000 | |||||||||||||||||||||||||||||
contract assets, net of allowance of 404 and 0 | 12,484,000 | |||||||||||||||||||||||||||||
prepaid expenses and other | 18,203,000 | 23,000,000 | 18,000,000 | 12,000,000 | 14,000,000 | 19,000,000 | 20,000,000 | 20,000,000 | 27,000,000 | 18,000,000 | 18,000,000 | |||||||||||||||||||
operating lease right-of-use assets | 20,015,000 | |||||||||||||||||||||||||||||
debt issuance costs | 2,760,000 | |||||||||||||||||||||||||||||
current portion of financing obligations | 698,000 | |||||||||||||||||||||||||||||
current portion of operating lease liability | 5,947,000 | |||||||||||||||||||||||||||||
accrued interest | 9,899,000 | 29,000,000 | 20,000,000 | 11,000,000 | 20,000,000 | 11,000,000 | 20,000,000 | 11,000,000 | 20,000,000 | 12,000,000 | 32,000,000 | |||||||||||||||||||
senior term loan, net of debt issuance costs of 482 and 593 | 348,528,000 | |||||||||||||||||||||||||||||
financing obligations, net of current portion | 55,005,000 | |||||||||||||||||||||||||||||
stock option liability | 37,661,000 | |||||||||||||||||||||||||||||
long-term disability insurance | 10,003,000 | |||||||||||||||||||||||||||||
unrecognized tax benefits, net of current portion | 1,911,000 | |||||||||||||||||||||||||||||
operating lease liability, net of current portion | 25,848,000 | |||||||||||||||||||||||||||||
common stock - 0.01 par value, 250,000,000 shares authorized; 57,469,391, shares issued and 30,903,450 shares outstanding at september 30, 2020; and 57,443,282 shares issued and 33,490,526 shares outstanding at december 31, 2019 | 575,000 | |||||||||||||||||||||||||||||
deferred directory costs | 121,000,000 | 136,000,000 | 150,000,000 | 161,000,000 | 161,000,000 | 177,000,000 | 179,000,000 | 183,000,000 | 168,000,000 | 147,000,000 | ||||||||||||||||||||
pension assets | 42,000,000 | 44,000,000 | 49,000,000 | 45,000,000 | 60,000,000 | 53,000,000 | 42,000,000 | 41,000,000 | 43,000,000 | 50,000,000 | ||||||||||||||||||||
other non-current assets | 2,000,000 | 6,000,000 | 6,000,000 | |||||||||||||||||||||||||||
liabilities and shareholders' | ||||||||||||||||||||||||||||||
current maturities of long-term debt | 2,298,000,000 | 124,000,000 | 132,000,000 | 124,000,000 | 123,000,000 | 131,000,000 | 153,000,000 | 154,000,000 | 160,000,000 | 162,000,000 | ||||||||||||||||||||
accounts payable and accrued liabilities | 111,000,000 | 122,000,000 | 132,000,000 | 167,000,000 | 133,000,000 | 135,000,000 | 135,000,000 | 166,000,000 | 177,000,000 | 189,000,000 | ||||||||||||||||||||
deferred revenue | 68,000,000 | 76,000,000 | 85,000,000 | 93,000,000 | 97,000,000 | 110,000,000 | 120,000,000 | 126,000,000 | 112,000,000 | 116,000,000 | ||||||||||||||||||||
long-term debt | 2,211,000,000 | 2,250,000,000 | 2,272,000,000 | 2,320,000,000 | 2,385,000,000 | 2,473,000,000 | 2,521,000,000 | 2,691,000,000 | 2,776,000,000 | |||||||||||||||||||||
employee benefit obligations | 117,000,000 | 118,000,000 | 125,000,000 | 127,000,000 | 89,000,000 | 121,000,000 | 115,000,000 | 132,000,000 | 163,000,000 | 169,000,000 | ||||||||||||||||||||
unrecognized tax benefits | 11,000,000 | 11,000,000 | 11,000,000 | 11,000,000 | 13,000,000 | 14,000,000 | 14,000,000 | 19,000,000 | 23,000,000 | 51,000,000 | ||||||||||||||||||||
shareholders' | ||||||||||||||||||||||||||||||
common stock | 0.1 | |||||||||||||||||||||||||||||
retained | -2,759,000,000 | -2,692,000,000 | -2,650,000,000 | -2,591,000,000 | -2,446,000,000 | -2,387,000,000 | -2,302,000,000 | -2,220,000,000 | -1,639,000,000 | -1,507,000,000 | ||||||||||||||||||||
accumulated other comprehensive | -81,000,000 | -83,000,000 | -82,000,000 | -85,000,000 | -25,000,000 | -30,000,000 | -32,000,000 | -34,000,000 | -54,000,000 | -50,000,000 | ||||||||||||||||||||
total shareholders' | -1,284,000,000 | -1,219,000,000 | -1,177,000,000 | -1,122,000,000 | ||||||||||||||||||||||||||
total liabilities and shareholders' | 1,419,000,000 | 1,494,000,000 | 1,600,000,000 | 1,722,000,000 | ||||||||||||||||||||||||||
cash flows from operating activities | ||||||||||||||||||||||||||||||
net | -168,000,000 | -101,000,000 | -59,000,000 | |||||||||||||||||||||||||||
reconciliation of net (loss) to net cash from operating activities: | ||||||||||||||||||||||||||||||
depreciation and amortization | 310,000,000 | 209,000,000 | 106,000,000 | |||||||||||||||||||||||||||
benefit from deferred income taxes | -14,000,000 | -4,000,000 | -3,000,000 | |||||||||||||||||||||||||||
benefit from unrecognized tax benefits | ||||||||||||||||||||||||||||||
benefit from bad debts | 15,000,000 | 8,000,000 | 5,000,000 | |||||||||||||||||||||||||||
non-cash interest expense | 82,000,000 | 53,000,000 | 25,000,000 | |||||||||||||||||||||||||||
stock-based compensation expense | 2,000,000 | 1,000,000 | 1,000,000 | |||||||||||||||||||||||||||
employee retiree benefits | 7,000,000 | 2,000,000 | 1,000,000 | |||||||||||||||||||||||||||
employee benefit plan amendments | ||||||||||||||||||||||||||||||
gains on early extinguishment of debt | -1,000,000 | |||||||||||||||||||||||||||||
changes in assets and liabilities: | ||||||||||||||||||||||||||||||
other items | -3,000,000 | -1,000,000 | ||||||||||||||||||||||||||||
net cash from operating activities | 199,000,000 | 136,000,000 | 46,000,000 | |||||||||||||||||||||||||||
cash flows from investing activities | ||||||||||||||||||||||||||||||
additions to fixed assets and capitalized software | -11,000,000 | -9,000,000 | -3,000,000 | |||||||||||||||||||||||||||
sales of fixed assets | 5,000,000 | 5,000,000 | ||||||||||||||||||||||||||||
net cash (used in) investing activities | -6,000,000 | -4,000,000 | -3,000,000 | |||||||||||||||||||||||||||
cash flows from financing activities | ||||||||||||||||||||||||||||||
debt repayments | -167,000,000 | -107,000,000 | -38,000,000 | |||||||||||||||||||||||||||
debt issuance costs and other financing items | -5,000,000 | -5,000,000 | -5,000,000 | |||||||||||||||||||||||||||
net cash (used in) financing activities | -172,000,000 | -112,000,000 | -43,000,000 | |||||||||||||||||||||||||||
increase in cash and cash equivalents | 21,000,000 | 20,000,000 | ||||||||||||||||||||||||||||
cash and cash equivalents, beginning of year | 171,000,000 | 171,000,000 | 171,000,000 | |||||||||||||||||||||||||||
cash and cash equivalents, end of period | 192,000,000 | 191,000,000 | 171,000,000 | |||||||||||||||||||||||||||
supplemental information | ||||||||||||||||||||||||||||||
cash interest on debt | 177,000,000 | 122,000,000 | 66,000,000 | |||||||||||||||||||||||||||
cash income taxes | 7,000,000 | 7,000,000 | 3,000,000 | |||||||||||||||||||||||||||
gain on early extinguishment of debt | -1,000,000 | |||||||||||||||||||||||||||||
assets held for sale | 12,000,000 | 15,000,000 | 16,000,000 | 16,000,000 | 21,000,000 | 21,000,000 | ||||||||||||||||||||||||
other non‑current assets | 7,000,000 | 12,000,000 | 15,000,000 | 17,000,000 | ||||||||||||||||||||||||||
balance, december 31, 2011 | ||||||||||||||||||||||||||||||
net income | ||||||||||||||||||||||||||||||
issuance of equity based awards | ||||||||||||||||||||||||||||||
other comprehensive income, net of tax | ||||||||||||||||||||||||||||||
balance, december 31, 2012 | ||||||||||||||||||||||||||||||
acquisition of supermedia | ||||||||||||||||||||||||||||||
balance, december 31, 2013 | ||||||||||||||||||||||||||||||
balance, december 31, 2014 | ||||||||||||||||||||||||||||||
other non current assets | 9,000,000 | 9,000,000 | 11,000,000 | |||||||||||||||||||||||||||
liabilities and shareholders' equity | ||||||||||||||||||||||||||||||
shareholders' equity | ||||||||||||||||||||||||||||||
total shareholders' equity | -918,000,000 | -864,000,000 | -782,000,000 | -703,000,000 | -142,000,000 | -6,000,000 | ||||||||||||||||||||||||
total liabilities and shareholders' equity | 1,898,000,000 | 2,084,000,000 | 2,275,000,000 | 2,464,000,000 | 3,358,000,000 | 3,701,000,000 | ||||||||||||||||||||||||
unbilled accounts receivable | 131,000,000 | 242,000,000 | ||||||||||||||||||||||||||||
accrued tax receivable | 11,000,000 | 12,000,000 | ||||||||||||||||||||||||||||
current deferred tax liabilities | 33,000,000 | |||||||||||||||||||||||||||||
liabilities and shareholder's equity | ||||||||||||||||||||||||||||||
total liabilities | ||||||||||||||||||||||||||||||
shareholder's equity | ||||||||||||||||||||||||||||||
total liabilities and shareholder's equity | 0.1 |
We provide you with 20 years of balance sheets for Thryv stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Thryv. Explore the full financial landscape of Thryv stock with our expertly curated balance sheets.
The information provided in this report about Thryv stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.